Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dermatology
Clinical study of Oracea capsules with MetroGel for rosacea released
March 2nd, 2007
CollaGenex Pharmaceuticals, Inc. (CGPI) announced results of a Phase IV clinical study designed to evaluate the efficacy of combining Oracea capsules and topical MetroGel in the treatment of rosacea. Study results were presented at the American Academy of Dermatology (AAD) Annual Meeting in Washington D.C. by the lead investigator, Joseph Fowler, MD, clinical professor of Dermatology, University of Louisville, Louisville, Kent. The trial also evaluated the effectiveness of Oracea for maintenance therapy in the treatment of rosacea. The double-blind, placebo-controlled trial enrolled a total of 72 rosacea patients at 3 centers. The patients were...
Source: Drug Week (2007-03-02)
|
